Hatib, Bb Boy E.

HRN: 25-65-26  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/07/2024
12/14/2024
IV
230mg
Q6h
PCAP
Waiting Final Action 
04/19/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/19/2025
04/26/2025
IV
380mg
Q6H
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: